Insider Trading & Ownership of Roy D. Baynes

Location: San Diego, CA
Summary: The estimated net worth of Roy D. Baynes is at least $4,832,979 dollars as of 21 Nov 2025. Roy D. Baynes is the Director of Natera, Inc. and owns shares of Natera, Inc. (NTRA) stock worth about $4,128,682. Roy D. Baynes is the Director of Travere Therapeutics, Inc. and owns shares of Travere Therapeutics, Inc. (TVTX) stock worth about $687,375. Roy D. Baynes is the Director of Atara Biotherapeutics, Inc. and owns shares of Atara Biotherapeutics, Inc. (ATRA) stock worth about $16,922.
Signature: /s/ Vincent Fontanilla, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Roy D. Baynes files a new Insider Trading report.

Ownership of Roy D. Baynes

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
NTRA	Natera, Inc.	Director	$4,128,682	-$2,809,689	-40.5%	19 Nov 2025
TVTX	Travere Therapeutics, Inc.	Director	$687,375	-$540,000	-44%	15 May 2025
ATRA	Atara Biotherapeutics, Inc.	Director	$16,922			23 Jun 2022
AARD	Aardvark Therapeutics, Inc.	Director				11 Jun 2025
NRIX	Nurix Therapeutics, Inc.	Director				19 May 2025

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.